Madison Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Madison Wealth Management's IBB Position: Q3 2023 in Review
Madison Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 18% in Q3 2023, selling an estimated $48.3K and leaving 1,722 shares worth $211K. The position accounts for 0.04% of the portfolio, ranked #148.
Madison Wealth Management first reported a position in IBB in Q4 2019 and has held it in 16 quarters since. The position peaked at $4.86M in Q4 2019. 833 funds tracked by Wall St. Rank hold IBB as of Q3 2023.
- Madison Wealth Management held 1,722 shares of iShares Biotechnology ETF worth $211K as of Q3 2023.
- Madison Wealth Management sold 380 iShares Biotechnology ETF shares in Q3 2023, an estimated $48.3K.
- iShares Biotechnology ETF made up 0.04% of Madison Wealth Management's portfolio in Q3 2023, its #148 holding.
- Madison Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 16 quarters since.
- Madison Wealth Management's iShares Biotechnology ETF position peaked at $4.86M in Q4 2019.
- 833 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2023.
Based on Madison Wealth Management's 13F filing for Q3 2023, filed 7 Nov 2023.